– PT2977 (MK-6482) is an orally active and selective HIF-2? inhibitor with an IC50 of 9 nM. PT2977, as a second-generation HIF-2? inhibitor, increases potency and improves pharmacokinetic profile. PT2977 is a potential treatment for clear cell renal cell carcinoma (ccRCC)[1].